Showing results (1-10 of 239) with videos related to
Sort By:
Pageof 24
Current Opinion in Endocrinology, Diabetes, and Obesity|February 19, 2014
Treatment options for low high-density lipoproteinsAnouar Hafiane, Samantha Kellett, Jacques GenestBBA Clinical|December 18, 2015
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskAnouar Hafiane, Jacques GenestAnnals of Clinical and Laboratory Science|December 15, 2015
HDL-Mediated Cellular Cholesterol Efflux Assay MethodAnouar Hafiane, Jacques GenestAtherosclerosis|January 28, 2017
ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesisAnouar Hafiane, Jacques GenestThe Canadian Journal of Cardiology|June 2, 2019
ABCA1 Agonist Mimetic Peptide CS-6253 Induces Microparticles Release From Different Cell Types by ABCA1-Efflux-Dependent MechanismAnouar Hafiane, Jan O Johansson, Jacques GenestThe Canadian Journal of Cardiology|January 9, 2017
High-Density Lipoproteins: Biology, Epidemiology, and Clinical ManagementHong Y Choi, Anouar Hafiane, Adel Schwertani, et al.Biochimica Et Biophysica Acta|August 6, 2014
Apolipoprotein E derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitroAnouar Hafiane, John K Bielicki, Jan O Johansson, et al.The American Journal of Cardiology|November 12, 2013
High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromesAnouar Hafiane, Bashar Jabor, Isabelle Ruel, et al.Plos One|July 25, 2015
Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In VitroAnouar Hafiane, John K Bielicki, Jan O Johansson, et al.Pageof 24